Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.
about
Capecitabine in the management of colorectal cancerTreatment of colorectal cancer in the elderlyManagement of locally advanced and metastatic colon cancer in elderly patientsCan we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an exampleEfficacy, compliance and reasons for refusal of postoperative chemotherapy for elderly patients with colorectal cancer: a retrospective chart review and telephone patient questionnaireDecision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancerCapecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancerFirst-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study.Chemotherapy for colorectal cancer in the elderly.First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer.Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer--results from a non-interventional observation study.Chemotherapy for elderly patients with advanced colorectal carcinoma.A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancerManagement of hand-foot syndrome induced by capecitabine.A review of the role of capecitabine in the treatment of colorectal cancer.Colorectal cancer treatment in older patients.Capecitabine in the treatment of advanced gastric cancer.Effect of age on drug metabolism in women with breast cancer.Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study.Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.Safety of capecitabine: a review.Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review).Treatment of colorectal cancer in older patients.Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?An exploratory study to identify risk factors for the development of capecitabine-induced Palmar Plantar Erythrodysesthesia (PPE).The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients.Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer.Complete response to capecitabine in a frail, elderly patient with metastatic colorectal cancer: A case report.Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients.A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese population.Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer.
P2860
Q24633039-87DA51F3-B4AC-49A4-8557-2A49A471B20DQ26781457-FCF57152-CEF8-4F80-95A4-157AC1CB346FQ27026129-8FCE441C-EE6A-474E-8A02-6EADC25DCA4BQ28069620-A99ECAEC-9D1F-4A57-AB14-157795B61BAFQ28486580-A5710FE4-72D3-4719-8156-B63F88E4B4F8Q30244769-AD60D2D1-511D-4058-AA29-C933F861D182Q33370632-8542E2CE-ABF4-41C6-B6A2-D269493193ECQ33847848-8EEF7615-6470-4E68-BCD3-091B1CC05100Q33918152-3B99B51D-C29F-41B5-BFAB-948100918205Q35567604-36891DAF-D187-4B75-9656-B1A4AC8BF68AQ35863869-681E2767-0FFB-4C8F-9681-FBDC4D9CB350Q35885143-83D9C0FD-4098-4221-93DA-237A2DE2DE8CQ35920292-8B999965-808A-4722-8946-0E99DDDB20E0Q36499252-6134922A-C9B2-44D8-8FE4-5F7327E278BEQ36614004-F6796639-AF7F-42B4-B437-B6835B93068FQ36615314-1AA753ED-FDCE-487F-A36E-12F321F5F8CEQ36661290-B3F45AD3-9ECF-4349-90DE-BE788AB0A575Q37073448-AE46F436-700F-4809-ADE9-93E878A48718Q37136996-81C24C9C-986E-44C4-837F-52DEAD8E797FQ37325560-5038825C-D915-4F52-ADA6-471396AE78A4Q37653406-F6DBDCA5-B530-4D04-BFAE-25707BFF1827Q37771244-312CDBD1-188C-4E2D-BA31-6E70F2E7AF52Q37781051-3F621122-19F0-4D6A-B36D-454AD21616CFQ38032558-57A26FC0-2485-46FA-B008-2291957B85E5Q38050375-FD7EDA0B-D0F4-4AAF-90EE-1516FDAE6A2EQ38216008-699C9000-8CC5-4EE8-943E-119BAABA6B1EQ38363625-5519D09E-BF78-44E2-BD45-1ACAC1AF03AFQ41231669-0F0B2F81-5865-45A8-B47C-A4CF67AF8184Q41559464-8014019C-C758-471A-9CC3-188C5672F68AQ42255078-C2441FFA-00AB-42F6-A6CF-CAB3303B830CQ42353597-6104DE8A-D393-47F2-8752-A9D82618F2D8Q47291560-1D30204D-E809-4147-891C-702303E74F8CQ53476543-5F498115-818D-464F-AF7D-D928D504D574
P2860
Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Capecitabine as first-line tre ...... copaz cooperative group study.
@ast
Capecitabine as first-line tre ...... copaz cooperative group study.
@en
type
label
Capecitabine as first-line tre ...... copaz cooperative group study.
@ast
Capecitabine as first-line tre ...... copaz cooperative group study.
@en
prefLabel
Capecitabine as first-line tre ...... copaz cooperative group study.
@ast
Capecitabine as first-line tre ...... copaz cooperative group study.
@en
P2093
P356
P1476
Capecitabine as first-line tre ...... copaz cooperative group study.
@en
P2093
Alfonso Yubero
Enrique Casado
Ferrán Llosa
Jaime Feliu
Jose-Javier Sanz-Lacalle
Jose-Manuel Vicent
Luis Lopez-Gómez
Manuel González-Baron
María-José Gómez-Reina
Matilde Bolaños
P304
P356
10.1200/JCO.2005.06.035
P407
P577
2005-05-01T00:00:00Z